The influence of h-carotene (BC) and its derivatives on differentiation, proliferation and apoptosis in three human acute leukemia cell lines was studied. We investigated: (i) the cellular uptake of BC, (ii) the cytotoxicity, (iii) the effect on cell cycle progression and/or apoptosis. The dose-and time-dependent pattern of cellular BC uptake in all studied cell lines was seen. We did not observe any cytotoxic effect of BC and ATRA in the chosen concentrations. There was only limited effect of BC on gene expression. The microarrray analysis of U-937 cell line exposed to BC for 72 h showed an increased expression of BAX gene. This finding was confirmed by real-time Q-PCR analysis, and supported by a flow cytometry apoptosis tests. We did not observe any influence of studied components on cellular proliferation. The induction of differentiation after incubation with ATRA in HL-60 cells was noted. The induction of cellular apoptosis by BC was seen in all studied cell lines. We demonstrated that BC used in the concentrations achievable in vivo does not affect the proliferation and differentiation process of the studied leukemic cell lines, but can influence and enhance the apoptosis by modulating the expression of the regulatory genes. D
Introduction
The nutritional factors can influence the processes as cellular differentiation, the apoptosis programme and proliferative cell potential. There is considerable laboratory evidence that antioxidant vitamins and related micronutrients are able to influence the carcinogenic process by regulation of gene expression, thus playing an important role in the pathogenesis of cancer [1] [2] [3] [4] [5] [6] . There is an epidemiological agreement, that h-carotene appears to have the strongest protective effect in lowering the risk of cancer [1, 6] . However, The Beta-Carotene and Retinol Efficacy Trial (CARET) in USA and The Alpha-Tocopherol/Beta-Carotene (ATBC) Trial in Finland have demonstrated that h-carotene increases both lung-cancer incidence and mortality in smokers, alcohol drinkers and people working with asbestos [5] . h-Carotene is metabolized in the mammalian cells and serves as an natural source of human vitamin A and retinoic acid (RA). hCarotene derivatives have been documented recently to be important for cellular differentiation and apoptosis activity [7, 8] . All-trans retinoic acid (ATRA) is one of the physiologic agents able to regulate the proliferation and differentiation of hematopoietic cells [9] .There is experimental evidence that h-carotene itself can modulate molecular pathways involved in the cell cycle progression and enhance the apoptosis [8, 10] . This study was aimed to elucidate some aspects of the h-carotene and its derivatives influence on leukemic cells, such as differentiation, proliferation and apoptosis in three human acute leukemia cell lines (HL-60, U-937, TF-1).
Materials and methods
We investigated: (i) the cellular uptake of h-carotene to establish the relevant in vitro model for further studies, (ii) the cytotoxicity of h-carotene and some derivatives (ATRA), alone or in the presence of the common in food fatty acids such as palmitic acid, and (iii) the effect of hcarotene on cell cycle progression and/or apoptosis in leukemic cell lines. In particular we evaluated the expression of cyclin kinase inhibitor (p21WAF-1/CIP-1) and apoptosis-related proteins (BCL-2, BCL-xL, BAX, MCL-1, BAD, and BAK) in U-937 cells using microarray technology, and evaluated the p21WAF-1/CIP-1 and BAX genes expression using real-time PCR method.
Cell cultures
All of the studied cell lines were obtained from ATCC-LGC Promochem (USA). The human promyelocytic leukemia HL-60 cell line (ATCC CCL-240), human myelomonocytic U-937 cell line (ATCC CRL-1593.2) and human erythroleukemic TF-1 cell line (ATCC CRL-2003) were maintained in RPMI 1640 medium (Gibco BRL, Grand Island, NY) supplemented with 10% heat-inactivated Newborn Calf Serum (NCS) (Sigma, Saint Louis, USA) and 1% glutamine gentamycine (Sigma, Saint Louis, USA) at 5% CO 2 /air atmosphere. To the TF-1 cell line, 1% of growth factor (GM-CSF) was added to the medium.
Reagents
h-Carotene (Roche Vitamins AG, Kaiseraugst, Switzerland) in a concentration of 10 AM was delivered to the cells (10 6 cells/ml) using tetrahydrofuran (THF) (0.25%) and ethanol (1:1) as a solvent (Trekli). All-trans Retinoic Acid (ATRA) (Sigma, Saint Louis, USA) was dissolved in 100% ethanol to a final concentration of 100 mM. The stock solutions of h-carotene (30 AM) and ATRA (10 mM) were prepared in dark conditions before each experiment and stored at À20 8C. Palmitic acid (PA) (Sigma, Saint Louis, USA) was dissolved in 100% ethanol and 0.1 M KOH in proportion 3:1 to a final concentration of 100 mM. The stock solution was diluted in growth medium to final concentrations from 1 AM to 250 AM. The medium containing h-carotene, ATRA, or PA was replaced every 24 h throughout the experiments.
Monitoring the cellular uptake of b-carotene
h-Carotene was dissolved in equal parts of tetrahydrofurane (THF) and ethanol and added to the medium. At the selected time intervals (24, 48 and 72 h) the cells were analyzed for h-carotene concentration and stability (lack of degradation products) in the culture medium. h-Carotene content in cells was examined by HPLC with a micromethod adapted from Roche using the Shimadzu SCL-1AVP instrument (Shimadzu, Kyoto, Japan) with the SPD-10AV detector (450 nm) as previously described (Trekli).
Detection of cytotoxicity
Cytotoxicity was measured after 24 h, 48 h and 72 h of incubation with h-carotene (10 AM), ATRA (0,1 AM), PA (1 AM and 30 AM) using CytoTox 96R Non-Radioactive Cytotoxicity Assay (Promega, Madison, USA). The red formazan-a product of conversion of a tetrazolium salt (INT)-was quantified by measuring the absorbance at respective wavelength using a scanning multiwell spectrophotometer (ELISA reader). Data are presented as percentage of cytotoxicity of treated cells versus cytotoxicity of control cells.
Regulation of gene expression
The gene expression changes in the U-937 cell line were assessed after 72 h of incubation with 10 AM beta-carotene vs. the solvent control.
RNA extraction
Total cellular RNA was isolated from 10Â10 6 cells using TRIzol (Gibco BRL, Grand Island, NY) according to the manufacturer's instruction. To obtain excellent quality of RNA, the samples were purified using RNA Mini Kit (QIAGEN, Hilden, Germany) according to the manufacturer's instructions. The RNA amount was measured using spectrophotometer (ThermoSpectronic-Genesis 2 Milton Ray, Rochester, USA). A 20 Ag of total RNA was electrophoresed with addition MOPS buffer to verify the quality of RNA.
cDNA synthesis
cDNA was synthesized using 50 ng of aliquots of total RNA primed with oligo d(T) primers in 25 Al reactions in thermocycler DYAD (MJ Research, Waltham, USA). To test for contamination by genomic DNA, additional reactions were done without adding reverse transcriptase.
Microhybridization
A standard protocol for the expression analysis of eukaryotic cells by the human-density U133A chips (Affymetrix, USA), including hybridization of fragmented biotin-labeled cRNA molecules and double phycoerythrin staining was used. We analyzed 15 Ag of RNA per one chip with detection of fluorescent signal by Affymetrix, USA GeneChipRScanner 3000 System with GeneChipROperating Software Version 1.0. All expression changes of separately hybridized RNA samples were evaluated using the same software by the comparison of the appropriate pair of chips.
The results of microarray hybridization for the CIP-1 and BAX gene were verified by the real-time PCR using the DNA Engine OpticonR 2 Continuous Fluorescence Detection System (MJ Research, Waltham, MA, USA) and SYBRRGreen as a fluorescent dye. For the real-time PCR quantitative analysis the cell line was cultured thrice and sampled after 24, 48 and 72 h.
Specific primers for human CIP-1 (p21), BAX and GAPDH were purchased from TIB MOLBIOL (Poznań, Polska). Three sets of primers were designed, which amplified BAX isoforms alpha, beta, epsilon, sigma (forward: GAAGCTGAGCGAGTGTCTC AAG; reverse:GTC-CACGGCGGCA ATC), and all of those plus delta (forward: AACTGGGGCCGGGTTGT; reverse: CAGTTCCGG-CACC TTGGT). All primer sets have similar izoform specificities as the two BAX probe sets on the U133A Affymetrix chip, 208478 _ s _ at and 211833 _ s _ at respectively. The PCR primers for GAPDH, used as an endogenous calibrator and p21/CIP-1/WAF-1 were: forward: CCAGG CGCCCAATACGA; reverse: GCCAGCCGAGCCACATC. The standardized protocol for the comparative threshold cycle (CT) method was used as described elsewhere (USER). Real-time PCR was performed using 2 Al of cDNA, QuantiTec SYBRR Green PCR Kit (QiAGEN, Hilden, Germany) and standard recommended amplification conditions. The results were presented as a change of CT between the stimulated target and control gene normalized against the calibrator (À2DDCT). The DDCT method was used for quantification after validation experiments in which almost identical amplification efficiencies (close to 2) of GAPDH and both BAX primer sets were proved. Subsequent experiments were carried out on 50 ng aliquots of total RNA reversed transcribed with oligo-dT primers using the Omniscript RT Kit (QIAGEN, Hilden, Germany) and PCR amplified with specific primers using the QuantiTect SYBR Green PCR Kit (QIAGEN, Hilden, Germany) and standard recommended amplification conditions with the annealing temperature of 60 8C. All PCR products underwent sequencing to check their specificity. In each run additionally a melting curve analysis was performed to confirm single peaks of specific products in all samples.
Analysis of cell proliferation
The cell proliferation was examined by the colorimetric ELISA BrdU assay (Roche, Mannheim, Germany) at 24, 48 and 72 h of culture in 96-well plates according to the manufacturer's instructions. The absorbance was measured using microtiter plate reader at 450 nm wavelength.
Monitoring the induction of cellular differentiation
Differentiation of cell lines was assessed biochemically by their ability to produce superoxide as measured by the reduction of nitroblue tetrazolium (NBT) to formazan (Sigma, Saint Louis, USA) in NBT assay. Data were presented as percentage of NBT-positive cells (differentiated cells) versus NBT-negative cells (immature cells).
The changes of cellular phenotype
The differentiation status of cells before and after all experiments was evaluated by the flow cytometry method. The following murine anti-human antibodies were used: CD4, CD11b, CD14 CD45, CD117 and additionally CD16 for U-937 cell line, HLA-DR for HL-60 cell line and CD 34 for TF-1 cell line (Becton Dickinson, Mountain View, CA). A multicolor analysis of cell surface molecules was performed using flow cytometer FACSCalibur (Becton Dickinson, Mountain View, CA).
Detection of apoptosis
Apoptosis was determined by flow cytometry analysis. Cells were stained with Annexin V and propidium iodide (PI) (Pharmingen), measured on a FACSCalibur flow cytometer, and analyzed with CellQuest software (Becton Dickinson). Apoptotic cells were defined as early apoptotic cells (annexin V positive and PI negative) and late apoptotic cells (annexin V and PI positive). Data were presented as percentage of apoptotic cells versus non-apoptotic cells in every samples). The apoptotic effect was measured additionally by the cell cycle analysis using TUNEL method (ApoDirect test, Pharmingen): 3Â10 6 cells were treated with FITC-dUTP in the presence of TdT enzyme, which incorporates FITC-dUTP into the 3V-hydroxyl-DNA ends, found in apoptotic cells. Cells were then stained with propidium iodide and analyzed on Becton Dickinson FACSscan.
Statistical analysis
Each experimental point from RQ-PCR analysis was measured in triplicate. The mean value and standard deviation was then calculated. Student t test for small samples was used for analysis of obtained results. Statistically significant values was set at the level of Pb/=0.05.
Results

Monitoring the cellular uptake of b-carotene
The HPLC analysis confirmed the successful uptake of hcarotene by all studied cell lines. The uptake of h-carotene expressed as pmol/10 6 cells showed dose-and time-depend-ent pattern in all studied cells ( Fig. 1 ) with only slight differences in the amounts of h-carotene incorporated between cell lines. The cellular uptake analysis allowed to establish an optimal h-carotene-delivery system to the studied cells giving a reliable basis for the evaluation of treatment.
b-Carotene cytotoxicity
We did not observe any cytotoxic effect of BC and ATRA after 24 h, 48 h and 72 h of incubation in chosen concentration (10 AM and 0,1 AM respectively) on studied cells. Due to the substantial cytotoxicity of PA after 48 h of incubation in a concentration higher than 15 
Effect of b-carotene on the expression of genes involved in apoptosis
The experiments performed with the use of high-density human Affymetrix chips revealed only limited effects of beta-carotene on gene expression, as far as the number of regulated genes (overall numbers of up-and downregulated genes were 55/307 (Table 1 ) and the overall magnitude of change in studied cells are regarded. The overall magnitude of the expression change was moderate with up to 95% of genes being regulated less than 2-fold. The microarray analysis of U-937 cell line exposed to beta-carotene for 72 h showed an increased expression (+2,4) of BAX gene. The finding of BAX increased expression was confirmed by real-time PCR quantitative expression analysis. The expression of BAX was enhanced in response to h-carotene at all three time points with the maximal rise slightly below the 2-fold mark after 72 h (Fig. 2) . The results were almost identical for both primer sets and supported by a flow cytometry apoptosis tests. The expression of genes involved in the cell cycle and apoptosis were not significantly influenced by incubation with used components (we did not observe a significant changes of BCL-2, MCL-1, BAD, BAK and p21/CIP-1/ WAF-1 and other genes involved in the cell cycle and apoptosis in the microarray analysis of studied cell lines). The results of the microarray study were confirmed for p21/ CIP-1/WAF-1 by real-time PCR quantitative expression analysis.
Effect of b-carotene on cell proliferation
The 24, 48 and 72 h coincubation of HL-60, U-937 and TF-1 cell lines with h-carotene, ATRA and PA did not reveal any influence on cellular proliferation ( P=0.04).
Effect of b-carotene on cell differentiation
The NBT test analysis was consistent with the flow cytometry findings. NBT-positive cells appeared and grad- (Fig. 3) . However there was no such influence of ATRA on other cell lines. h-Carotene and PA showed no differentiating effect on U-937, HL-60, and TF-1 cells in flow cytometry analysis.
Effect of b-carotene on apoptosis
The studied cells were cultured with or without 10 AM h-carotene for up to 72 h, and then examined the induction of apoptosis. The influence of h-carotene on apoptosis was examined by flow cytometry. The induction of cellular apoptosis by h-carotene was seen in all studied cell lines in the time dependent manner. The 72 h incubation of cells with h-carotene increased the number of annexin Vpositive cells representing late and early apoptotic cells (Fig. 4) . The apoptotic effect was measured additionally by the cell cycle analysis using the TUNEL method ( showing increasing number of apoptotic cells after incubation with h-carotene in all studied cell lines.
Discussion
In this study we evaluated in vitro the effect of hcarotene used in the concentrations achievable in vivo on the proliferation, differentiation and apoptosis of leukemic cell lines. We studied the expression of BCL-2, BAX, BCL-X, MCL-1, BAD, BAK and p21/CIP-1/WAF-1 and other genes involved in the cell cycle and apoptosis after 24, 48 and 72 h of incubation with 10 AM of h-carotene. The microarray analysis performed in our study revealed a relatively small number of genes regulated by h-carotene and moderate overall magnitude of their expression change. Observed limited response to this compound could be at least partially explained by the fact, that the concentration of h-carotene (10 AM) used in our experiments was non-toxic, but relatively low. Such concentration was chosen to eliminate the possible toxic effect on studied cells and to be in the range found in serum of human subjects supplemented with 50 mg/day [11] and 51 to 102 mg three times per day [12] of h-carotene (16.1 AM and 2 to 13.2 AM respectively). Interestingly, after more detailed analysis a particular pattern of regulation could be noticed. The majority of genes regulated by h-carotene including important genes coding for proteins involved in cell division and DNA replication reveal the lowering of the expression. The h-carotene-induced inhibition of several genes responsible for vital cellular functions of leukemic cell line revealed in our study is an interesting observation. The microarray data pointed to an increased expression of the proapoptotic protein BAX in the U-937 cell line after 72 h of incubation with h-carotene. BAX could be a candidate gene to play a role in mediating the h-carotene cellular effects. BAX codes for the X-protein, which associates with BCL-2 and has well characterized pro-apoptotic activity involved in the p53-mediated pathway of apoptosis. The consequence of X-protein binding to the mitochondrial membrane anion channel is the release of the cytochrome c into the cytoplasm, which results in apoptogenic activation of caspases [13] . The increased expression of BAX in the microarray was confirmed by the quantitative expression analysis using real-time PCR. Additionally the increase of BAX expression in our experiments was strictly related to apoptosis induction evaluated by the morphological cellular changes assessment and flow cytometry. As demonstrated above even small changes in the mRNA BAX expression was capable of eliciting a significant cellular response. These findings are in accord once with other reports demonstrating the h-carotene induced apoptosis in different cell types [8, 10, 14] . In contrast to the study performed on human colon adenocarcinoma [10] and undifferentiated HL-60 [8] cell lines, the expression of proteins: bcl-2, bcl-xL, mcl-1, and bad belonging to BCL-2 gene family in our leukemic cell lines was not affected by h-carotene. This could point to the cellular differences in sensitivity to hcarotene and different molecular pathways involved in the development of end point biological effects characteristic for this compound [15] . The ability of h-carotene to inhibit cell growth has been established in several tumor cells including melanoma [16] , prostate [3] , colon [10] , lung, breast and oral mucosa cancer [2] . The lack of induction of proliferation or differentiation by h-carotene observed in our experiments could be in accord once with findings, that the carotenoid induced modification of cell cycle leads to cell growth inhibition and induction of apoptosis of undifferentiated cells [8, 10] . This effect could be the result of the different metabolic status of cells and different membrane composition [10] . Such results suggest that carotenoids aside from ATRA could have some therapeutical applicability in hamatological malignancies [14, 17] . Despite the different h-carotene cellular incorporation rate among used leukemic cell lines, the studied cells have been behaving in the similar way, showing any significant effect of h-carotene itself on their differentiation and proliferation. Sokolosky as well as Palozza reported recently, that NF-kappB was suspected to be the factor regulating the differentiation of leukemic cells [18, 19] . The incubation of HL-60 cells with h-carotene resulted in a significant increase in reactive oxygen species (ROS), which was accompanied by a sustained elevation of NF-kappaB DNA-binding activity, increased expression of its target gene-c-myc-and significant inhibition of cell growth as a consequence [19] . In the above study h-carotene when used alone revealed no significant effect on HL-60 cell differentiation, however it increased markedly the differentiation induced by the vitamin D3, probably through the reduction of the nuclear content of NF-kappaB [18] . In our microarray analysis of genes expression in h-carotene treated HL-60, U-937, and TF-1 cells, neither the NF-kappaB nor its target gene c-myc expression were altered. The p21WAF-1/CIP-1-a cyclin kinase inhibitor gene plays an important role in the regulation of cell cycle and apoptosis. The encoded protein p21 is the PML-RAR alpha target gene and mediates p53 suppression of tumor cell growth. It is known that overexpression of p21 in tumor cell line suppresses colony formation similar to that resulting from p53 overexpression [20] . Many cytostatic drugs used in the treatment of acute leukemias, such as doxorubicin and etoposide induce apoptosis through a p53 dependent pathway [21] . Therefore an increase of p21 expression could theoretically support the antileukemic activity of commonly used in the treatment of acute myeloid leukemia cytostatics. We evaluated the p21WAF-1/CIP-1 gene expression in HL-60, U-937 and TF-1 after 72 h of incubation with 10 AM of h-carotene. In all studied cells the expression of p21 gene was not significantly changed in microarray analysis. These findings were confirmed for the HL-60 cell line by the real-time PCR quantitative expression analysis. Similar results were obtained when ATRA was used for experiments. In summary we demonstrated that h-carotene used in the concentration achievable in vivo in humans serum after this compound supplementation does not affect the proliferation and differentiation process of studied in vitro leukemic cell lines. h-Carotene can enhance the expression of the BAX gene, one of the regulator genes of apoptosis, in U-937 leukemic cell line. Because of the comparable to the in vivo h-carotene concentrations which were used in our study we suggest that our results give a rational basis and approach for the putative clinical effect of this compound to be suggested.
